XORTX THERAPEUTICS: WHY THIS COMPANY IS WORTH INVE
Post# of 26
XRTX
Excited to share latest coverage on XORTX Therapeutics Inc. (NASDAQ: XRTX), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease.
The Company has major upcoming catalysts that could prove to be transformative.
Read on to find out more!
https://www.aviseanalytics.com/xortx-therapeu...esting-in/